IPIC Message Board - Msg: 4147086

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC

IPIC 0.0001000

0.0%

Aug 15 3:35 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: margaret foley who wrote (1188)	4/21/1998 5:05:00 PM
From: KS	of 1359

There is still hope. From their press release... "The Company is proceeding on schedule with its other lead product development programs. Results from a Phase 2/3 clinical trial with pagoclone for panic/anxiety are expected in late summer 1998. In addition, the Company is conducting an ongoing Phase 3 clinical trial with BEXTRA(TM) (bucindolol) for congestive heart failure. Interneuron plans to continue its business strategy of development of its pipeline and continued in-licensing of new products. The Company may explore financing opportunities to further this strategy." Holding, watching, hoping...long. K

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next